Yahoo Web Search

  1. Acceleron Pharma Inc (XLRN) Q2 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceAug 06 15:23 PM

    Our three ongoing placebo-controlled Phase 2 trials, two with ACE-083 and one with sotatercept, have each completed patient enrollment and will help to establish proof of concept with ...

  2. Agios' (AGIO) Loss Widens in Q2, Tibsovo Drives Sales

    Zacks via Yahoo FinanceAug 01 16:02 PM

    Agios Pharmaceuticals, Inc. AGIO reported second-quarter 2019 loss of $1.87 per share, wider than the Zacks Consensus Estimate of a loss of $1.73 and also the year-ago loss of $1.19.

  3. Catalyst's (CPRX) Q2 Earnings and Revenues Beat Estimates

    Zacks via Yahoo FinanceAug 08 13:26 PM

    Catalyst Pharmaceuticals, Inc. CPRX reported earnings of 10 cents per share in the second quarter of 2019, which beat the Zacks Consensus Estimate of 3 cents. The company’s revenues of ...

  4. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Microsoft Corporation ...

  5. Philippines ‘Iron Lady’ Leads Push for Fair Alcohol Taxes

    Bloomberg via Yahoo FinanceAug 05 5:42 AM

    She’s leading the Distilled Spirits Association of the Philippines -- a decade-old group she helped establish that includes billionaires Lucio Tan’s Tanduay Distillers Inc., Ramon Ang ...

  6. Sarepta Therapeutics, Inc. SRPT incurred an adjusted loss of 83 cents per share in the second quarter of 2019, wider than the year-ago loss of 43 cents per share. The Zacks Consensus ...

  7. Viking Therapeutics, Inc. (VKTX) is currently preparing for the initiation of a Phase 2b clinical trial of VK2809, the company’s thyroid beta receptor (TRβ) agonist, for the treatment ...

  8. 5 Best Stocks to Ride Out U.S.-China Trade Tensions

    Zacks via Yahoo FinanceAug 07 11:49 AM

    President Trump recently threatened fresh tariffs on Chinese imports, provoking China to the extent that it let the yuan sink and has been labelled as a currency manipulator. Aggravating things ...

  9. A sale would come at a delicate time for Foxconn, which has extensive investments in China, a large roster of U.S. clients that includes Apple Inc, and is having to navigate a tricky ...

  10. Novo Nordisk (NVO) Q2 Earnings & Revenues Beat Estimates

    Zacks via Yahoo FinanceAug 09 13:27 PM

    Novo Nordisk A/S NVO reported second-quarter 2019 earnings of 61 cents per American Depositary Receipt (ADR), slightly beating the Zacks Consensus Estimate of 60 cents but decreasing from the ...